1. Home
  2. YUMC vs VTRS Comparison

YUMC vs VTRS Comparison

Compare YUMC & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yum China Holdings Inc.

YUMC

Yum China Holdings Inc.

HOLD

Current Price

$48.86

Market Cap

17.5B

ML Signal

HOLD

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$14.99

Market Cap

17.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YUMC
VTRS
Founded
1987
1961
Country
China
United States
Employees
N/A
30000
Industry
Restaurants
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.5B
17.5B
IPO Year
2016
2019

Fundamental Metrics

Financial Performance
Metric
YUMC
VTRS
Price
$48.86
$14.99
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$13.50
AVG Volume (30 Days)
1.2M
8.3M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
2.38%
3.21%
EPS Growth
7.73
N/A
EPS
2.51
N/A
Revenue
$11,797,000,000.00
$14,299,900,000.00
Revenue This Year
$9.42
$4.41
Revenue Next Year
$5.86
$1.96
P/E Ratio
$19.31
N/A
Revenue Growth
4.37
N/A
52 Week Low
$41.69
$8.19
52 Week High
$58.39
$16.47

Technical Indicators

Market Signals
Indicator
YUMC
VTRS
Relative Strength Index (RSI) 46.30 64.68
Support Level $47.74 $12.90
Resistance Level $49.25 $15.22
Average True Range (ATR) 0.97 0.39
MACD 0.13 0.09
Stochastic Oscillator 45.60 88.03

Price Performance

Historical Comparison
YUMC
VTRS

About YUMC Yum China Holdings Inc.

Yum China is the largest restaurant operator in China, with over 18,000 locations and USD 12 billion in systemwide sales as of 2025. It generates revenue mainly from its own restaurants and franchise fees. While KFC and Pizza Hut are its flagship brands, Yum China's portfolio also includes Little Sheep, Taco Bell, Huang Ji Huang, and Lavazza. As a trademark licensee of Yum Brands, Yum China pays 3% of KFC and Pizza Hut's systemwide sales to its former parent, from which it spun off in 2016. However, even before the separation, Yum China was granted substantial autonomy, giving its Chinese leadership decision-making authority over menu, supply chain, and marketing-an unusual practice for Western chains at the time.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: